Simplex Trading
SCMP

Simplex Trading’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Simplex Trading’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-21,200
Closed -$380K – 7462
2017
Q4 		$380K Buy
+21,200
New +$261K 0.02% 862
2017
Q3 		– Sell
-6,112
Closed -$68.6K – 7180
2017
Q2 		$64K Buy
6,112
+3,155
+107% +$32.2K ﹤0.01% 2167
2017
Q1 		$32K Buy
+2,957
New +$34.3K ﹤0.01% 2796
2016
Q3 		– Sell
-4,477
Closed -$52.8K – 6918
2016
Q2 		$49K Sell
4,477
-2,501
-36% -$28K ﹤0.01% 2090
2016
Q1 		$76K Buy
6,978
+5,878
+534% +$74.3K 0.01% 1585
2015
Q4 		$19K Sell
1,100
-3,095
-74% -$55.5K ﹤0.01% 2765
2015
Q3 		$83K Buy
4,195
+286
+7% +$6.56K 0.01% 1562
2015
Q2 		$64K Sell
3,909
-7,029
-64% -$122K 0.01% 1523
2015
Q1 		$170K Buy
10,938
+10,109
+1,219% +$157K 0.02% 796
2014
Q4 		$12K Buy
+829
New +$8.76K ﹤0.01% 2491

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Simplex Trading's SCMP Position: Q1 2018 in Review

Simplex Trading sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 21,200 shares — an estimated $380K sold.

Simplex Trading first reported a position in SCMP in Q4 2014 and held it in 10 quarters. The position peaked at $380K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Simplex Trading reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Simplex Trading sold 21,200 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $380K.
  • Simplex Trading first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2014 and held it in 10 quarters.
  • Simplex Trading's Sucampo Pharmaceuticals, Inc. position peaked at $380K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Simplex Trading's 13F filing for Q1 2018, filed 26 Apr 2018.